Table V.
Correlation between oxidative activity and the studied parameters in patients with psoriasis or psoriatic arthritis and in controls
| Parameter | Patients with psoriatic arthritis or psoriasis | Controls | ||
|---|---|---|---|---|
| Rs | P-value | Rs | P-value | |
| TC | 0.34 | < 0.05 | 0.21 | 0.2549 |
| HDL-C | 0.23 | 0.1224 | 0.06 | 0.7384 |
| LDL-C | 0.23 | 0.1187 | 0.27 | 0.1316 |
| VLDL | -0.02 | 0.8896 | 0.18 | 0.3122 |
| TG | -0.07 | 0.6210 | 0.18 | 0.3122 |
| ApoA | 0.26 | 0.0900 | 0.12 | 0.5263 |
| ApoB | 0.39 | < 0.01 | -0.07 | 0.7091 |
| ApoA : ApoB ratio | 0.25 | 0.0939 | -0.08 | 0.6582 |
| TC : HDL-C ratio | 0.08 | 0.5777 | 0.11 | 0.5618 |
| API | -0.15 | 0.3076 | 0.10 | 0.5878 |
| LDL-C : HDL-C ratio | 0.11 | 0.4475 | 0.12 | 0.5231 |
| ApoB : ApoA ratio | 0.24 | 0.1159 | -0.10 | 0.6100 |
| LDL-C : ApoB ratio | -0.25 | 0.0934 | 0.28 | 0.1253 |
TC – total cholesterol, HDL-C – high-density lipoprotein cholesterol, LDL-C – low-density lipoprotein cholesterol, VLDL – very low-density lipoprotein, TG – triglycerides, ApoA – apolipoprotein A, ApoB – apolipoprotein B, API – atherogenic index of plasma. Significant correlations are marked in bold.